Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM(@KOBPharmD) 's Twitter Profileg
Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM

@KOBPharmD

Clinical Pharmacy Specialist #ambcarerx All things #diabetes and #CGM Opinions are my own. she/her/hers

ID:1174093128632066049

calendar_today17-09-2019 22:49:57

1,9K Tweets

1,5K Followers

1,5K Following

Endocrine Today(@EndocrineToday) 's Twitter Profile Photo

🚨 The U.S. FDA has designated the EversenseCGM as an integrated and will allow the device to be used with insulin pumps and automated insulin delivery systems.

Read more ⤵️ Ascensia Diabetes Care

healio.com/news/endocrino…

account_circle
Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM(@KOBPharmD) 's Twitter Profile Photo

Cant wait for the scientific sessions, great learning &networking! Register today, hope to see you there.

I’ll be speaking on a panel Saturday: “The Role of the Interdisciplinary Team in Technology Onboarding in Primary Care”

account_circle
American Diabetes Association - DiabetesPro(@ADA_DiabetesPro) 's Twitter Profile Photo

Encourage people living with diabetes to join us for an Ask the Experts event on Tuesday, April 9 at 2:00 p.m. ET. We'll be discussing medications used to manage diabetes and the types that can work best. Register at bit.ly/49bxEcK.
Susan G. Weiner, RD

Encourage people living with diabetes to join us for an Ask the Experts event on Tuesday, April 9 at 2:00 p.m. ET. We'll be discussing medications used to manage diabetes and the types that can work best. Register at bit.ly/49bxEcK. #KnowDiabetesbyHeart @susangweiner
account_circle
Pancreassassin(@Pancreassassin) 's Twitter Profile Photo

Do you use Humalog or Lilly’s lispro in 10mL bottles? It may be hard to come by starting April, per Lilly.

lilly.com/our-medicines/…

account_circle
Jimmy L. Pruitt III, PharmD, BCPS, BCCCP, BCEMP(@PharmD_intheED) 's Twitter Profile Photo

Phase 2 does not mean inferior program or candidate.

Decrease candidate pool + ⬆️ competition for certain programs = ⬆️ unmatched programs/candidates

Just my opinion

account_circle
Dave Sugrue(@DSugsPharmD) 's Twitter Profile Photo

We have 1 PGY1 position at Duke Raleigh Hospital available in Phase II of the match. Please share with candidates who are looking for a great well rounded PGY1!

#TwitteRx We have 1 PGY1 position at Duke Raleigh Hospital available in Phase II of the match. Please share with candidates who are looking for a great well rounded PGY1!
account_circle
U.S. FDA(@US_FDA) 's Twitter Profile Photo

Today, we approved a new indication for use for an injectable medication to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight. fda.gov/news-events/pr…

This injection should be used in…

Today, we approved a new indication for use for an injectable medication to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight. fda.gov/news-events/pr… This injection should be used in…
account_circle
Joshua Neumiller(@JoshuaNeumiller) 's Twitter Profile Photo

It was a real pleasure working with Wendy St. Peter and Jay SHUBROOK on this review discussing opportunities for pharmacists to improve outcomes for people with T2D and CKD JCM MDPI

doi.org/10.3390/jcm130…

It was a real pleasure working with @WendyStPeter002 and @jay_shubrook on this review discussing opportunities for pharmacists to improve outcomes for people with T2D and CKD @JCM_MDPI doi.org/10.3390/jcm130…
account_circle
U.S. FDA(@US_FDA) 's Twitter Profile Photo

Today, FDA cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM). fda.gov/news-events/pr…

Today, FDA cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM). fda.gov/news-events/pr…
account_circle
Brendon Neuen(@brendonneuen) 's Twitter Profile Photo

Announcement from Novo Nordisk re the FLOW trial:

Semaglutide reduced the risk of 50% decline in eGFR, kidney failure, or death due to kidney or cardiovascular disease by 24%

Results to be presented this year by trial PI Vlado Perkovic & colleagues

novonordisk.com/content/nncorp…

account_circle